Skip to main content
. 2016 Dec 1;55(23):3495–3497. doi: 10.2169/internalmedicine.55.7104

Figure.

Figure.

Graphical presentation of the present cases. Clinical courses of the two cases, A) case 1 and B) case 2, are presented. The time from the start of nilotinib is shown by the vertical line. The dotted line indicates the upper normal limit of pancreatic amylase (P-AMY).